Key Takeaways
- Depression is medically classified as Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD/dysthymia), or other specifier types — each with distinct treatment paths.
- First-line evidence-based treatments include CBT, IPT, SSRIs/SNRIs, and (for treatment-resistant depression) TMS, ketamine/esketamine, and ECT.
- Roughly 30–40% of people don’t respond fully to a first antidepressant trial. Treatment-resistant depression has its own evidence-based protocols.
- Residential and PHP/IOP care is appropriate when outpatient treatment isn’t working, when there is suicidal ideation, or when daily functioning has collapsed.
- Federal Mental Health Parity law requires most insurance plans to cover depression treatment at the same level as physical health care.
Depression affects more than 21 million U.S. adults each year. It is a treatable illness, not a personal weakness. The right level of care — from outpatient therapy to a 30-day residential program — depends on the severity of your symptoms, whether you’ve responded to prior treatment, and whether other conditions like anxiety or substance use are in the picture.
This guide explains how clinicians classify depression, the treatments with the strongest evidence base, and how to know when residential or intensive outpatient care makes sense. If you or someone you love is struggling, our admissions team can match you with a licensed program that fits your clinical needs, insurance, and budget — at no cost to you.
How Depression Is Diagnosed
A licensed clinician — typically a psychiatrist, psychologist, or psychiatric nurse practitioner — diagnoses depression using the DSM-5-TR criteria. For Major Depressive Disorder (MDD), at least five of nine symptoms must be present nearly every day for two weeks or longer, and at least one symptom must be either depressed mood or loss of interest/pleasure (anhedonia).
The other seven symptoms include significant weight or appetite change, sleep disturbance (insomnia or hypersomnia), psychomotor agitation or slowing, fatigue, feelings of worthlessness or excessive guilt, difficulty concentrating, and recurrent thoughts of death or suicide. Severity is rated mild, moderate, or severe based on the number of symptoms, their intensity, and how much they interfere with daily life.
Persistent Depressive Disorder (formerly dysthymia) is a lower-grade but longer-lasting depression — symptoms present most days for at least two years in adults. Other specifiers include peripartum onset, seasonal pattern, and with anxious distress.
Evidence-Based Treatments for Depression
Decades of clinical research point to a small set of treatments with the strongest outcomes:
Cognitive Behavioral Therapy (CBT) teaches you to identify and restructure the distorted thought patterns that fuel depressive episodes. Most controlled trials show CBT performs at least as well as antidepressant medication for mild-to-moderate depression, and the relapse rate is lower.
Interpersonal Therapy (IPT) focuses on the relational stressors — grief, role transitions, interpersonal conflict — that often trigger depressive episodes. It is particularly effective for postpartum and grief-related depression.
Behavioral Activation is a shorter, more action-oriented protocol that uses structured scheduling of rewarding activities to break the depression-inactivity cycle. It can be delivered in primary care and shows excellent outcomes.
Antidepressant medication — most commonly SSRIs (sertraline, escitalopram, fluoxetine), SNRIs (venlafaxine, duloxetine), or atypicals (bupropion, mirtazapine) — works for roughly 50–60% of patients on a first trial. Combining medication with psychotherapy typically outperforms either alone for moderate-to-severe depression.
Treatment-Resistant Depression
If two adequate antidepressant trials at therapeutic dose haven’t produced meaningful improvement, the depression is considered treatment-resistant. This is more common than people realize — somewhere between 30% and 40% of patients fall into this category. Evidence-based options at this point include:
Transcranial Magnetic Stimulation (TMS) — an FDA-cleared, non-invasive procedure that uses magnetic pulses to stimulate underactive regions of the prefrontal cortex. Standard protocols run daily for 4–6 weeks. Insurance typically covers TMS after documented failure of two antidepressants.
Esketamine (Spravato) — a nasal spray derivative of ketamine, FDA-approved in 2019 for treatment-resistant depression and approved in 2020 for acute suicidal ideation. Administered under medical supervision at certified clinics.
Electroconvulsive Therapy (ECT) remains the most effective treatment available for severe, medication-resistant, or psychotic depression. Modern protocols use brief-pulse, unilateral ECT under anesthesia, with response rates above 70%.
Augmentation strategies — adding lithium, an atypical antipsychotic (aripiprazole, brexpiprazole), or a second antidepressant from a different class — can also be effective and are typically lower-cost options.
Levels of Care for Depression
The choice of treatment setting is driven by severity, safety, and what’s already been tried:
| Level of Care | When It Fits | Typical Length |
|---|---|---|
| Outpatient Therapy | Mild–moderate depression; no safety concerns | Weekly, ongoing |
| Intensive Outpatient (IOP) | Moderate depression; needs more structure than weekly therapy | 8–12 weeks, 3 days/week |
| Partial Hospitalization (PHP) | Severe depression; daily structure but home at night | 2–6 weeks, 5 days/week |
| Residential | Severe/treatment-resistant; functional collapse; safety concerns | 30–90 days |
| Inpatient Hospital | Active suicidal crisis or unsafe at home | 3–10 days, then step-down |
Residential depression treatment programs typically combine daily individual therapy, group therapy, psychiatric medication management, and adjunctive services — TMS, sleep restoration, nutrition counseling, exercise, and trauma-informed therapy when relevant. The 30-day length of stay is the most common, but 60- and 90-day programs are appropriate for treatment-resistant or co-occurring presentations.
When Substance Use Is in the Picture
Depression and substance use disorder co-occur at very high rates — roughly one in three adults with a major depressive episode also meets criteria for a substance use disorder in the same year. Treating one without the other rarely works. Integrated dual diagnosis programs treat both conditions simultaneously through a coordinated clinical team. See our Dual Diagnosis page for a deeper explanation of how integrated care works.
Insurance Coverage and Cost
The federal Mental Health Parity and Addiction Equity Act (MHPAEA) requires most large group health plans to provide depression treatment coverage at least equivalent to coverage for physical health conditions. In practice, that means:
- Outpatient therapy is almost always covered, usually with a per-session copay.
- IOP, PHP, and residential care typically require pre-authorization and concurrent review, but are covered when medically necessary.
- TMS is covered by most major plans after documented failure of two antidepressants.
- Out-of-network programs may be partially reimbursable depending on your plan’s out-of-network benefits.
Our admissions team will run a free verification of benefits and tell you in plain language what your specific plan will and won’t cover before you commit to any program.
Frequently Asked Questions
How do I know if I need residential treatment or just outpatient therapy?
If outpatient treatment has stopped working, if you’ve had thoughts of self-harm, if you can no longer hold work or family responsibilities, or if your depression is severe enough that getting out of bed is a daily struggle, residential care is appropriate. A clinical assessment with one of our admissions counselors is free and takes about 30 minutes.
How long does residential depression treatment usually last?
Most programs are structured around 30, 60, or 90 days. Insurance typically authorizes care in 7- to 14-day blocks based on continued medical necessity. The clinical team will recommend a discharge plan when you’ve stabilized and have a safe step-down to PHP, IOP, or outpatient care in place.
Will my insurance cover depression treatment?
Under the federal Mental Health Parity Act, most plans must cover depression treatment at the same level as physical health care. Specific coverage varies by plan, level of care, and in-network vs. out-of-network programs. We verify benefits at no cost and can give you exact numbers before you commit.
What is treatment-resistant depression?
When two adequate antidepressant trials at therapeutic dose haven’t produced meaningful improvement, the depression is considered treatment-resistant. Evidence-based options at this point include TMS, esketamine (Spravato), ECT, and medication augmentation strategies. Residential programs that specialize in treatment-resistant depression typically combine these with intensive psychotherapy.
Is medication required, or can I treat depression with therapy alone?
For mild-to-moderate depression, evidence-based psychotherapy alone (CBT, IPT, or behavioral activation) can produce outcomes comparable to medication. For moderate-to-severe depression, the combination of medication plus psychotherapy typically outperforms either approach alone. The decision is yours in collaboration with your treatment team.